These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10674022)

  • 1. Suppressive subtractive hybridisation reveals differential expression of serglycin, sorcin, bone marrow proteoglycan and prostate-tumour-inducing gene I (PTI-1) in drug-resistant and sensitive tumour cell lines of haematopoetic origin.
    Beyer-Sehlmeyer G; Hiddemann W; Wörmann B; Bertram J
    Eur J Cancer; 1999 Nov; 35(12):1735-42. PubMed ID: 10674022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of ribosomal proteins L4 and L5 and the putative alternative elongation factor PTI-1 in the doxorubicin resistant human colon cancer cell line LoVoDxR.
    Bertram J; Palfner K; Hiddemann W; Kneba M
    Eur J Cancer; 1998 Apr; 34(5):731-6. PubMed ID: 9713282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated expression of S100P, CAPL and MAGE 3 in doxorubicin-resistant cell lines: comparison of mRNA differential display reverse transcription-polymerase chain reaction and subtractive suppressive hybridization for the analysis of differential gene expression.
    Bertram J; Palfner K; Hiddemann W; Kneba M
    Anticancer Drugs; 1998 Apr; 9(4):311-7. PubMed ID: 9635921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
    Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
    J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
    Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentially expressed genes associated with cisplatin resistance in human ovarian adenocarcinoma cell line A2780.
    Solár P; Sytkowski AJ
    Cancer Lett; 2011 Oct; 309(1):11-8. PubMed ID: 21676537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to methotrexate in SKOV-3 cell lines after chronic exposure to carbamazepine is associated with a decreased expression of folate receptor.
    Toffoli G; Corona G; Tolusso B; Sartor F; Sorio R; Mini E; Boiocchi M
    Int J Cancer; 2000 Mar; 85(5):683-90. PubMed ID: 10699949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Establishment of a human nasopharyngeal carcinoma drug-resistant cell line CNE2/DDP and screening of drug-resistant genes].
    Jiang RD; Zhang LX; Yue W; Zhu YF; Lu HJ; Liu X; Cen XT; Guan XY; Li CH
    Ai Zheng; 2003 Apr; 22(4):337-45. PubMed ID: 12703984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. shRNA-mediated silencing of sorcin increases drug chemosensitivity in myeloma KM3/DDP and U266/ADM cell lines.
    Xu P; Jiang YF; Wang JH
    Int J Clin Exp Pathol; 2015; 8(3):2300-10. PubMed ID: 26045737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential miRNA expression profiles in hepatocellular carcinoma cells and drug-resistant sublines.
    Zhuo L; Liu J; Wang B; Gao M; Huang A
    Oncol Rep; 2013 Feb; 29(2):555-62. PubMed ID: 23229111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of drug-regulated genes in osteosarcoma cells.
    Fellenberg J; Dechant MJ; Ewerbeck V; Mau H
    Int J Cancer; 2003 Jul; 105(5):636-43. PubMed ID: 12740912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sorcin (V19), a soluble acidic calcium-binding protein overproduced in multidrug-resistant cells. Identification of the protein by anti-sorcin antibody.
    Meyers MB; Schneider KA; Spengler BA; Chang TD; Biedler JL
    Biochem Pharmacol; 1987 Jul; 36(14):2373-80. PubMed ID: 3606647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of chemotherapeutic drug toxicity to human tumour cells in vitro by a subset of non-steroidal anti-inflammatory drugs (NSAIDs).
    Duffy CP; Elliott CJ; O'Connor RA; Heenan MM; Coyle S; Cleary IM; Kavanagh K; Verhaegen S; O'Loughlin CM; NicAmhlaoibh R; Clynes M
    Eur J Cancer; 1998 Jul; 34(8):1250-9. PubMed ID: 9849488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid recovery of a functional MDR phenotype caused by MRP after a transient exposure to MDR drugs in a revertant human lung cancer cell line.
    Gonzalez Manzano R; Versanvoort C; Wright K; Twentyman PR
    Eur J Cancer; 1996 Nov; 32A(12):2136-41. PubMed ID: 9014757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential over-expression of mdr1 genes in multidrug-resistant rat glioblastoma cell lines selected with doxorubicin or vincristine.
    Schott B; Bennis S; Pourquier P; Ries C; Londos-Gagliardi D; Robert J
    Int J Cancer; 1993 Aug; 55(1):115-21. PubMed ID: 8102127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-resistance to methotrexate and metals in human cisplatin-resistant cell lines results from a pleiotropic defect in accumulation of these compounds associated with reduced plasma membrane binding proteins.
    Shen D; Pastan I; Gottesman MM
    Cancer Res; 1998 Jan; 58(2):268-75. PubMed ID: 9443404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human prostatic carcinoma oncogene PTI-1 is expressed in human tumor cell lines and prostate carcinoma patient blood samples.
    Sun Y; Lin J; Katz AE; Fisher PB
    Cancer Res; 1997 Jan; 57(1):18-23. PubMed ID: 8988032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance of human larynx carcinoma cells to cisplatin, gamma-irradiation and methotrexate does not involve overexpression of c-myc or c-Ki-ras oncogenes.
    Osmak M; Beketić-Oresković L; Matulić M; Sorić J
    Mutat Res; 1993 Nov; 303(3):113-20. PubMed ID: 7694127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct mechanisms contribute to acquired cisplatin resistance of urothelial carcinoma cells.
    Höhn A; Krüger K; Skowron MA; Bormann S; Schumacher L; Schulz WA; Hoffmann MJ; Niegisch G; Fritz G
    Oncotarget; 2016 Jul; 7(27):41320-41335. PubMed ID: 27191498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulated expression of BCL2, MCM7, and CCNE1 indicate cisplatin-resistance in the set of two human bladder cancer cell lines: T24 cisplatin sensitive and T24R2 cisplatin resistant bladder cancer cell lines.
    Kim SH; Ho JN; Jin H; Lee SC; Lee SE; Hong SK; Lee JW; Lee ES; Byun SS
    Investig Clin Urol; 2016 Jan; 57(1):63-72. PubMed ID: 26966728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.